Vaginal News and Research

RSS

Expert suggests ways to control uncomfortable vaginal symptoms in diabetic women

With approximately 9.7 million women in the U.S. suffering with diabetes and almost 50 million U.S. adults with prediabetes, most of the women are experiencing uncomfortable vaginal symptoms like recurrent yeast and bacterial infections, vaginal dryness, reduced sexual interest, and painful intercourse that can adversely affect quality of life.

15 Nov 2018

Promising technology could improve detection, diagnosis of fatal ovarian cancer

Ovarian cancer claims the lives of more than 14,000 in the U.S. each year, ranking fifth among cancer deaths in women.

14 Nov 2018

Survey shows negative effect of vulvovaginal atrophy symptoms on quality of life for women

With symptoms such as dryness, burning, or itching of the vagina, vulvovaginal atrophy is estimated to affect up to 98% of postmenopausal women, many of whom will fail to report symptoms to their healthcare providers or seek help.

14 Nov 2018

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.

29 Oct 2018

King's researchers analyze potential risks of C-section

A series of papers published in the Lancet shows that globally the number of babies born through cesarean section (C-section) almost doubled between 2000 and 2015: from 12% to 21% of all births or nearly 30 million worldwide.

26 Oct 2018

Hospitals differ largely in using 'trial of labor after cesarean delivery'

Despite the conventional belief that for women giving birth "once a cesarean always a cesarean," vaginal delivery after cesarean -- also known as "trial of labor after cesarean delivery" -- offers a safe option for many second-time mothers with no contraindications.

25 Oct 2018

Study finds why pregnant women in mainland China, Hong Kong and Taiwan prefer cesarean delivery

Pregnant women in mainland China, Hong Kong, and Taiwan are more likely to express preference for cesarean section as their mode of delivery later in pregnancy and postpartum, as compared to early in pregnancy, according to a study published this week in PLOS Medicine.

19 Oct 2018

Self-lubricating condoms may help raise condom usage

Researchers have come up with self lubricating condoms that become slippery or lubricated once they come in contact with skin. This would not only raise the pleasure factor of condom usage they feel, but in turn also raise usage of condoms and reduce the incidence of sexually transmitted diseases (STDs) and unwanted pregnancies.

18 Oct 2018

Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis

According to an online survey, although healthcare providers report sharing crucial information on bacterial vaginosis with patients, the associated risks of the condition remain a mystery to many women, indicating a significant disconnect.

16 Oct 2018

New family planning app found to be as effective as modern methods

Early results from a first-of-its-kind study suggests that typical use of a family planning app called Dot is as effective as other modern methods for avoiding an unplanned pregnancy.

16 Oct 2018

Birth mode may have acute effects on neurodevelopment, study suggests

Cesarean-born mice show altered patterns of cell death across the brain, exhibiting greater nerve cell death than vaginally delivered mice in at least one brain area, a finding by Georgia State University researchers that suggests birth mode may have acute effects on human neurodevelopment that may lead to long-lasting changes in the brain and behavior.

16 Oct 2018

UNC researchers awarded $3.8 million grant to develop ultra-long-acting antiretroviral formulations

It has been well established that HIV transmission can be efficiently halted by effective treatment of those infected or by pre-exposure prophylaxis of individuals at risk of exposure.

11 Oct 2018

New study suggests vaginal laser surgery may be effective for treating menopause symptoms

Microablative fractional CO2 lasers are energy-based devices designed to help manage troublesome menopause symptoms such as painful sex, dryness, itching/burning, urinary frequency, and incontinence.

10 Oct 2018

Study examines effect of immediate vs delayed pushing during labor on delivery outcomes

The best time to push during the second stage of labor (when the cervix is completely dilated through delivery) is unknown and it's unclear whether the timing affects rates of natural delivery or possible complications.

10 Oct 2018

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.

6 Oct 2018

New combination therapy shows potential in treating incurable HPV-related cancers

A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related to the human papilloma virus (HPV) in a phase II clinical trial led by investigators at The University of Texas MD Anderson Cancer Center and reported in JAMA Oncology.

28 Sep 2018

New program combines basic science and social benefits to address HIV risk among young women

A program established by investigators from the Ragon Institute of Massachusetts General Hospital, MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from two angles - first, investigating biological factors that modulate infection risk along with the early immunologic events following viral exposure, and second, alleviating the socioeconomic factors that limit opportunities for young women, the group at greatest risk of infection in the region of the world hardest hit by the HIV epidemic.

17 Sep 2018

Vaginal News and Research

Expert suggests ways to control uncomfortable vaginal symptoms in diabetic women

Promising technology could improve detection, diagnosis of fatal ovarian cancer

Survey shows negative effect of vulvovaginal atrophy symptoms on quality of life for women

TherapeuticsMD announces FDA approval of BIJUVA capsules to manage vasomotor symptoms of menopause

King's researchers analyze potential risks of C-section

Hospitals differ largely in using 'trial of labor after cesarean delivery'

Study finds why pregnant women in mainland China, Hong Kong and Taiwan prefer cesarean delivery

Self-lubricating condoms may help raise condom usage

Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis

New family planning app found to be as effective as modern methods

Birth mode may have acute effects on neurodevelopment, study suggests

UNC researchers awarded $3.8 million grant to develop ultra-long-acting antiretroviral formulations

New study suggests vaginal laser surgery may be effective for treating menopause symptoms

Study examines effect of immediate vs delayed pushing during labor on delivery outcomes

FDA approves expanded use of Gardasil 9 for adults aged 27 to 45 years

New combination therapy shows potential in treating incurable HPV-related cancers

New program combines basic science and social benefits to address HIV risk among young women

Nerve stimulation therapy may offer new hope for women with sexual dysfunction

Scientists shed light on new possibilities for prevention of preterm birth

New study suggests chemotherapy may cause early menopause in women with lung cancer

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News